je.st
news
Home
› Boston Biomedical Announces Clinical Data Presentation Of Its Cancer Stem Cell Inhibitor Programs
Boston Biomedical Announces Clinical Data Presentation Of Its Cancer Stem Cell Inhibitor Programs
2014-06-16 19:56:43| Logistics - Topix.net
Clinical data were presented for BBI608 and BBI503, novel agents targeting cancer stem cells that have been developed by the company.
Tags: data
cell
programs
presentation
Category:Transportation and Logistics